Marijuana

Obtaining a medical marijuana card for chronic pain, insomnia, anxiety or depression led to a “rapid onset” of cannabis use disorder, according to researchers.

Healio’s most-viewed neurology stories in February highlight evidence of potential dangers of marijuana for brain health, the FDA expanding the indication of a hemorrhage detection device and an NIH grant to a biotech firm.

As medical marijuana becomes increasingly legal in the U.S., eye care providers are fielding more inquiries and making decisions about its use in the treatment of glaucoma, according to a study published in the Journal of Glaucoma.

In a new statement, the American Heart Association presented scientific evidence that challenges the belief that marijuana is harmless and highlights uncertainty about the drug’s effect on brain health.

Findings suggest that women who experience nausea and vomiting in early pregnancy may be self-medicating with marijuana, and obstetricians should be prepared to offer safe and effective treatment alternatives.

Among patients with aneurysmal subarachnoid hemorrhage, those with recent cannabis use were more likely to have delayed cerebral ischemia than those without recent use, researchers reported.

Elevated atherosclerotic CVD risk was linked to cannabis use in a study published in the American Journal of Cardiology.

Preterm infants who consume breast milk from mothers who have tested positive for THC do not experience any short-term health effects, although the long-term health effects remain uncertain, researchers reported.

An international panel of experts reported that non-inhaled medical cannabis or cannabinoids were associated with modest benefits in patients with chronic pain.

College students and peers of the same age are using marijuana at a rate not seen since the 1980s, according to an NIH-funded study.